Morgan Stanley raises target for CME Group stock to USD 359.00
Published on 10/26/2026 at 16:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and trading scale
- Morgan Stanley raised its CME Group target from USD 337.00 to USD 359.00 on October 22, 2026.
- CME Group recorded 29.40 million average daily contracts in the third quarter of 2026.
- CME Group stock costs EUR 274.55 at Lang & Schwarz on October 26, 2026 at 4:45 p.m. CEST, 0.53 percent above the Tradegate close.
CME Group Inc. (ISIN US12572Q1058) received a higher price target from Morgan Stanley, which lifted its target from USD 337.00 to USD 359.00 on October 22, 2026, according to Markets Insider. CME Group stock was trading at EUR 274.55 at Lang & Schwarz on October 26, 2026 at 4:45 p.m. CEST, up 0.53 percent versus the Tradegate close.
Trading activity sets a fresh high
The analyst action followed CME Group's third-quarter results, but the most useful operating measure for investors is trading activity. The company recorded average daily volume of 29.40 million contracts in the third quarter of 2026, a quarterly record. Non-US average daily volume reached 9.00 million contracts, according to CME Group.
Revenue reached USD 1.74 billion in the third quarter of 2026, compared with USD 1.54 billion in the third quarter of 2025, a 12.99 percent increase. Market data revenue rose to USD 243.10 million from USD 202.50 million, an increase of 20.05 percent. Adjusted diluted earnings per share came to USD 3.02, versus USD 2.68 a year earlier.
Stock remains below its yearly high
The Lang & Schwarz price sits within the primary-market 52-week range of USD 218.31 to USD 329.16. The primary Nasdaq quote was USD 306.81 at 11:56 a.m. ET on October 26, 2026, while the 52-week high was USD 329.16. That places the Nasdaq quote 6.79 percent below the high, leaving the price position more important than the modest euro-market move.
CME Group's valuation remains substantial. Its market capitalization was USD 110.3 billion, and its trailing P/E ratio was 25.17 on October 26, 2026. The dividend yield was 0.04 percent in the same quote snapshot.
Comparison with peers
CME Group: plus 0.36 percent, P/E 25.17, market capitalization USD 110.3 billion.
Intercontinental Exchange (NYSE, USD): minus 1.59 percent, P/E 22.62, market capitalization USD 89.9 billion.
Nasdaq (Nasdaq, USD): plus 1.26 percent, P/E 28.41, market capitalization USD 58.0 billion.
Why the target matters
Morgan Stanley's USD 359.00 target stands 17.01 percent above the USD 306.81 Nasdaq quote. The gap is a valuation reference, not a forecast from this article. CME Group's third-quarter operating figures provide the underlying comparison: revenue grew 12.99 percent year over year while average daily volume reached 29.40 million contracts.
Price and valuation
The stock's key tension is visible in the spread between strong operating activity and a valuation already above the peer average of 25.52 based on the two listed peers. The next market signal is whether volume growth and market data revenue can support the premium multiple.
The further course of trading is shown by the continuously updated real-time quote of CME Group stock.
CME Group stock at a glance
- Company: CME Group Inc.
- ISIN: US12572Q1058
- WKN: A0MW32
- Ticker: CME
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 26, 2026, 4:45 p.m. CEST): EUR 274.55
- Change versus Tradegate close: plus 0.53 percent
- Market capitalization: USD 110.3 billion (as of October 26, 2026)
- 52-week range: USD 218.31-USD 329.16 (as of October 26, 2026)
- Sector / Industry: Financial Services / Financial and Commodity Market Operators
- Index membership: S&P 500
Market context: Market report Nasdaq Composite.
